5 Undervalued Stocks to Buy After Earnings
Summary
Daniel identifies a divergence in the market where the broader index is rising while many individual stocks remain well below their peaks. He argues that this environment offers a significant amount of value for investors willing to look past the dominant mega-cap names. His thesis centers on identifying companies with double-digit growth rates and record-breaking fundamentals that have suffered from market-wide sector sell-offs or temporary margin compression.
Mentioned Stocks
Reasoning: Daniel notes the stock is 'ridiculously cheap' at 6.5x 2026 free cash flow expectations. He is impressed by the 20% reduction in share count and the founder buying $16 million worth of shares recently at $41 per share.
Reasoning: Daniel has been actively buying BAM, citing it as an 'AI winner' due to its infrastructure and energy assets. He provides a fair value price target of $70 per share and expects 20% annual earnings growth.
Reasoning: Daniel views Skyward as a high-growth specialty insurer trading at a significant discount (under 9x forward earnings). He highlights their perfect track record of meeting consensus and the CEO's confidence in beating 2026 guidance. He mentions the stock is currently trading around $45.58.
Reasoning: Daniel believes the 15% post-earnings drop is a buying opportunity. He argues that margin compression is a healthy sign of aggressive reinvestment into credit and ads (which grew 73%). He maintains that their credit portfolio quality is actually improving despite market fears.